Avelumab first-line maintenance

DRUG2 trials

Conditions

Bladder (Urothelial, Transitional Cell) Cancer Metastatic or UnresectableBladder CancerBladder TumorsUpper Tract Urothelial CancerUrinary Bladder NeoplasmsUrothelial Carcinoma

Phase 4

DDR Genes Alteration and Response to Platinum-based Chemotherapy in Advanced Urothelial Cancer.

RecruitingNCT06820255

Fondazione Policlinico Universitario Agostino Gemelli IRCCSBladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable, Upper Tract Urothelial Cancer

Start: 2025-01-07End: 2027-01-07Target: 135Updated: 2025-02-11

Unknown Phase

A Study to Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder Cancer

TerminatedNCT05699135

PfizerBladder Cancer, Bladder Tumors, Urinary Bladder Neoplasms +1

Start: 2023-03-09End: 2023-06-30Updated: 2024-04-24

Avelumab first-line maintenance

Sponsors

Conditions

Phase 4

Unknown Phase